学术探索
学术期刊
新闻热点
数据分析
智能评审

Staphylococcus aureus with reduced susceptibility to vancomycin

被引：100
作者：
Cosgrove, SE
Carroll, KC
Perl, TM
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pathol, Div Clin Microbiol, Baltimore, MD 21205 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2004年 / 39卷 / 04期
关键词：
D O I：
10.1086/422458
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Infections with Staphylococcus aureus with reduced susceptibility to vancomycin continue to be reported, including 2 cases caused by S. aureus isolates with full resistance to vancomycin. This review first outlines the definitions of vancomycin-intermediate S. aureus (VISA) and vancomycin-resistant S. aureus (VRSA) and risk factors for infection. Next, we describe the mechanisms of resistance and methods of laboratory detection of the organisms. Finally, we address infection control and management issues associated with isolation of VISA and VRSA.
引用
收藏
页码：539 / 545
页数：7
相关论文
共 31 条
[1]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P902
[2]  
[Anonymous], 2002, MMWR MORB MORTAL WKL, V51, P565
[3]   Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center [J].
Bozdogan, B ;
Esel, D ;
Whitener, C ;
Browne, FA ;
Appelbaum, PC .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (05) :864-868
[4]  
*CDCP, 2003, INV CONTR VANC INT R
[5]  
*CDCP DIV HEALTHC, 2003, VANC INT RES STAPH A
[6]   Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations [J].
Cha, R ;
Brown, WJ ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (12) :3960-3963
[7]   Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene [J].
Chang, S ;
Sievert, DM ;
Hageman, JC ;
Boulton, ML ;
Tenover, FC ;
Downes, FP ;
Shah, S ;
Rudrik, JT ;
Pupp, GR ;
Brown, WJ ;
Cardo, D ;
Fridkin, SK .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1342-1347
[8]   Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus [J].
Charles, PGP ;
Ward, PB ;
Johnson, PDR ;
Howden, BP ;
Grayson, ML .
CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) :448-451
[9]   Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin [J].
Climo, MW ;
Patron, RL ;
Archer, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) :1747-1753
[10]   Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus [J].
Cui, L ;
Ma, XX ;
Sato, K ;
Okuma, K ;
Tenover, FC ;
Mamizuka, EM ;
Gemmell, CG ;
Kim, MN ;
Ploy, MC ;
El Solh, N ;
Ferraz, V ;
Hiramatsu, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (01) :5-14
1234